Gubbi Sriram, Shahid Maham, Koch Christian A., Verbalis Joseph G.
Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA
Division of Endocrinology, Department of Medicine, University of Florida College of Medicine, Jacksonville, Florida, US
Diabetes insipidus (DI) is a disorder characterized by excretion of large volumes of hypotonic urine. The underlying cause is either a deficiency of the hormone arginine vasopressin (AVP) in the pituitary gland/hypothalamus [central DI )], or resistance to the actions of AVP in the kidneys [nephrogenic DI )]. In most circumstances, DI is also characterized by excessive consumption of water (polydipsia). A third condition called primary polydipsia can clinically show overlapping features with DI. Both DI and primary polydipsia are collectively referred to as ‘polyuria-polydipsia syndromes. Like other endocrine disorders, an accurate diagnosis of DI can be challenging. This is mainly because the results obtained from diagnostic testing can show significant overlap among the different forms of DI and primary polydipsia. When a case of DI is suspected, the initial step involves the confirmation of the presence of hypotonic polyuria, which is the hallmark of DI. Once hypotonic polyuria is established, the next step is to identify the type of polyuria-polydipsia disorder (central DI vs. nephrogenic DI vs. primary polydipsia). This can be determined either through the water deprivation test or through the copeptin stimulation tests using osmotic and non-osmotic AVP stimulants. Lastly, a detailed history and physical examination must be performed and appropriate laboratory and imaging studies must be undertaken to identify the underlying etiology of DI. This chapter describes the diagnostic steps to be pursued to identify the presence of DI, distinguish the various forms of polyuria-polydipsia disorders, identify the underlying disorders responsible for the DI, the challenges faced with diagnostic testing for DI in clinical practice, and future prospects in the field of DI diagnosis. For complete coverage of all related areas of Endocrinology, please visit our on-line FREE web-text, WWW.ENDOTEXT.ORG.
尿崩症(DI)是一种以大量排出低渗尿液为特征的疾病。其根本原因要么是垂体/下丘脑激素精氨酸加压素(AVP)缺乏(中枢性尿崩症),要么是肾脏对AVP作用产生抵抗(肾性尿崩症)。在大多数情况下,尿崩症还表现为饮水过多(烦渴)。第三种情况称为原发性烦渴,临床上可表现出与尿崩症重叠的特征。尿崩症和原发性烦渴统称为“多尿-烦渴综合征”。与其他内分泌疾病一样,准确诊断尿崩症具有挑战性。这主要是因为诊断测试结果在不同形式的尿崩症和原发性烦渴之间可能存在显著重叠。当怀疑患有尿崩症时,第一步是确认是否存在低渗性多尿,这是尿崩症的标志。一旦确定存在低渗性多尿,下一步就是确定多尿-烦渴症的类型(中枢性尿崩症与肾性尿崩症与原发性烦渴)。这可以通过禁水试验或高渗盐水输注试验以及血浆AVP或血浆copeptin测量来确定。最后,必须进行详细的病史和体格检查,并进行适当的实验室和影像学检查,以确定尿崩症的潜在病因。本章描述了用于识别尿崩症、区分各种形式的多尿-烦渴症、确定导致尿崩症的潜在疾病、临床实践中尿崩症诊断测试面临的挑战以及尿崩症诊断领域未来前景的诊断步骤。如需全面涵盖内分泌学的所有相关领域,请访问我们的在线免费网络文本,WWW.ENDOTEXT.ORG。